Přístupnostní navigace
E-application
Search Search Close
Other similar devices are limited to lab-scale use due to low volume capacity. However, CaviPlasma can purify up to fifteen thousand liters of water per hour, making it viable for practical applications. “Licenses for the CaviPlasma device were sold to two Czech companies. One of them – ABPLAST Group s.r.o. – has already commercialized the technology,” says Rudolf from BUT. ABPLAST Group s.r.o. is currently preparing the device for use in the fourth stage of wastewater treatment at biological treatment plants. “The biggest advantage of CaviPlasma lies in its versatility and cost-effectiveness when integrated into the water treatment process,” says Petr Stiller, Executive and Commercial Director of ABPLAST Group s.r.o.Representatives of this company, along with expert Pavel Rudolf from FME, are showcasing the unique technology in Japan. “At EXPO, we are presenting the second-generation CaviPlasma unit in dynamic demonstrations. We even had to manufacture a special transformer to convert Japanese electrical current to Czech standards,” says Petr Stiller.CaviPlasma device. | Author: archiv Pavla Rudolfa
The CaviPlasma technology perfectly demonstrates that Czech science has something to offer on the global stage. It benefits from top experts and the ability to connect academic research with societal and industrial needs. According to Pavel Rudolf from FME, Czech experts are capable of developing unique devices – from original ideas to commercial products. However, this wouldn’t be possible without interdisciplinary and industrial collaboration, as finding a company that sees commercial potential and can bring the development to completion is absolutely essential.“We can be proud that Czech technologies are part of the global world of science and research,” concludes Petr Stiller.
Responsibility: Bc. Tereza Kučerová